Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


EU Signs Deal for 405 Billion Doses of Potential German COVID Vaccine

VOA News

   The European Commission, the European Union's administrative branch,
   announced Monday a deal with to purchase 405 billion doses of a
   potential coronavirus vaccine from German bio-tech company CureVac.

   The announcement comes just days after EU officials announced a similar
   deal with German company BioNTech and U.S. pharmaceutical giant Pfizer
   for an initial 300 million doses of the vaccine candidate they jointly
   produced, which, they say, has proven 90 percent effective against
   COVID-19 in late-stage testing.

   European Commission President Ursula von der Leyen told reporters the
   deal with CureVac is, of course, conditional on their vaccine proving
   to be safe and effective.

   Von der Leyen said the fifth CureVac is fifth company the alliance has
   contracted with a for its COVID-19 vaccine portfolio.

.